Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million

The New York Times – Business:

The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery.

Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.